The abstract is read at the publisher; the summary is JClub's.
High CD24 expression in SW620 colorectal cancer cells is linked to macrophage-resistant immune evasion in zebrafish xenografts, and CD24 loss sensitizes tumors to clearance.
- Why it matters: Adaptive checkpoint therapies help only some patients, leaving innate immune evasion mechanisms in colorectal cancer as an underexploited therapeutic target.
- What they did: Zebrafish xenografts using isogenic SW480 and SW620 lines showed that human CD24 loss dramatically increases macrophage-mediated clearance, an effect abolished by pharmacological macrophage depletion. Mechanistically, CD24 limits myeloid recruitment, dampens TNF-driven macrophage polarization, and blocks phagocytosis, with live imaging showing a restrained patrol-like macrophage state.
- The result: Zebrafish macrophages respond to human CD24 despite extensive evolutionary divergence, and glycocalyx remodeling plus si:dkey-24p1.7 implicate sialic acid-dependent recognition; TCGA CRC analysis finds CD24 is stage-dependent prognostic.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.